Advanced Oxidation Nanoprocessing Boosts Immunogenicity of Whole Tumor Cells
Open Access
- 21 May 2023
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 10 (22) , e2302250
Abstract
Whole tumor cells expressing a wide array of tumor antigens are considered as a highly promising source of antigens for cancer vaccines. However, simultaneously preserving the antigen diversity, improving immunogenicity, and eliminating the potential tumorigenic risk of whole tumor cells are highly challenging. Inspired by the recent progress in sulfate radical‐based environmental technology, herein, an advanced oxidation nanoprocessing (AONP) strategy is developed for boosting the immunogenicity of whole tumor cells. The AONP is based on the activation of peroxymonosulfate by ZIF‐67 nanocatalysts to produce SO4−∙ radicals continuously, leading to sustained oxidative damage to tumor cells and consequently extensive cell death. Importantly, AONP causes immunogenic apoptosis as evidenced by the release of a series of characteristic damage associated molecular patterns and at the same time maintains the integrity of cancer cells, which is critical to preserve the cellular components and thus maximize the diversity of antigens. Finally, the immunogenicity of AONP‐treated whole tumor cells is evaluated in a prophylactic vaccination model, demonstrating significantly delayed tumor growth and increased survival rate of live tumor‐cell‐challenged mice. It is expected that the developed AONP strategy would pave the way to develop effective personalized whole tumor cell vaccines in future.Keywords
This publication has 36 references indexed in Scilit:
- Sulfate radicals induced from peroxymonosulfate by magnetic ferrospinel MFe2O4 (M = Co, Cu, Mn, and Zn) as heterogeneous catalysts in the waterApplied Catalysis B: Environment and Energy, 2015
- Influence of particle size of zero-valent iron and dissolved silica on the reactivity of activated persulfate for degradation of acid orange 7Chemical Engineering Journal, 2014
- Immunogenic Cell Death in Cancer TherapyAnnual Review of Immunology, 2013
- Immunogenic cell death and DAMPs in cancer therapyNature Reviews Cancer, 2012
- Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulinCancer Immunology, Immunotherapy, 2011
- An autoimmune-mediated strategy for prophylactic breast cancer vaccinationNature Medicine, 2010
- Sulfate radical-based ferrous–peroxymonosulfate oxidative system for PCBs degradation in aqueous and sediment systemsApplied Catalysis B: Environment and Energy, 2009
- In Vivo Vaccination With Tumor Cell Lysate Plus CpG Oligodeoxynucleotides Eradicates Murine GlioblastomaJournal of Immunotherapy, 2007
- CD4 cells can be more efficient at tumor rejection than CD8 cellsBlood, 2007
- Calreticulin exposure dictates the immunogenicity of cancer cell deathNature Medicine, 2006